From Sudoku to high-intensity workouts to playing the trombone, there are countless ways to challenge the brain – and maybe even stave off Alzheimer’s disease in the process. But according to a new study, speaking a second language may hold the real superpower when it comes to delaying cognitive decline.
In the study, published last month in the journal Alzheimer’s Disease and Associated Disorders, Toronto researchers found bilingual people with mild cognitive impairment, or slight but noticeable changes in mental function, progressed to full-blown Alzheimer’s disease more rapidly than their monolingual counterparts.
These findings support the idea that bilinguals may be able to live with Alzheimer’s disease in their brains for years, but function as though they do not, said co-author Ellen Bialystok, a distinguished research professor in York University’s department of psychology. This study builds on her previous research, suggesting bilingualism appears to increase people’s cognitive reserve – that is, their brain’s ability to withstand damage and decline.
Story continues below advertisement
As the disease progresses, however, and they are no longer able to compensate, “at some point, they’re going to deteriorate faster because they’re coping with substantially more disease,” she said.
When it comes to lifestyle activities that build cognitive reserve, language is particularly stimulating because we use it throughout our waking hours and it engages all parts of the brain, Bialystok said. But beyond that, people who know more than one language always have them available to them. There’s no switching one language off, she said, which means, even though they may not be aware of it, bilinguals are constantly selecting the language they need.
“That kind of selection is an ongoing cognitive demand of bilingualism,” Dr. Bialystok said.
In their latest study, conducted at Baycrest Health Sciences in Toronto, she and her team examined the patient records of 83 monolingual and 75 bilingual participants. While the team’s previous research has shown bilinguals were, on average, four years older than monolinguals when they received a dementia diagnosis, the participants of this study did not differ in age when they were eventually diagnosed with Alzheimer’s disease.
However, those in the bilingual group were about two years older, on average, than the monolingual group at the time of their mild cognitive impairment diagnosis.
The researchers found that it took an average of about 1.9 years for the bilingual participants to progress from mild cognitive impairment to an Alzheimer’s disease diagnosis, while for monolingual participants, it took an average of about 2.6 years. This suggests even though the two groups were matched at the start of the study in terms of their clinical symptoms, the bilingual patients were likely dealing with a greater level of disease, Bialystok said.
Illustrated on a graph, here’s what the two groups look like: A short platform with a gradual decline represents the cognitive function of the monolinguals, while a higher cliff, representing the bilingual participants with their higher cognitive reserve, ends in a steeper plunge.
Story continues below advertisement
At the University of Ottawa’s school of psychology, associate professor Vanessa Taler, who was not involved in the study, said she was excited by these findings, as they are consistent with previous research in the area.
Taler said it would be interesting to examine whether bilingualism has a protective effect for individuals with different subtypes of mild cognitive impairment. (Mild cognitive impairment is a very unstable concept, she said, as not all patients go on to develop dementia, while some even return to normal cognition.)
The age someone begins speaking a second language, how well and how often they use it, and which languages they speak, are other factors that may affect cognitive reserve, she said, but more study is needed.
“It’s cutting-edge work in this area, so that’s where we start,” she said.
Back in Toronto, Bialystok said people often ask whether it’s too late for them to learn a second language. Her answer: It’s unlikely for anyone to become fluent if they start studying another language late in life, so they would not get the same boost in cognitive reserve as a life-long bilingual speaker.
Nevertheless, she emphasized, anything that is challenging is good for the brain.
Story continues below advertisement
“As long as you’re using your brain in stimulating ways, you’re helping cognitive reserve,” she said. “If not language, then just make sure you’re doing something.”
Sign up for the weekly Health & Wellness newsletter, your source for nutrition news, fitness tips and wellness advice.
WASHINGTON (AP) — Americans can once again order COVID-19 tests, without being charged, sent straight to their homes.
The U.S. government reopened the program on Thursday, allowing any household to order up to four at-home COVID nasal swab kits through the website, covidtests.gov. The tests will begin shipping, via the United States Postal Service, as soon as next week.
The website has been reopened on the heels of a summer COVID-19 virus wave and heading into the fall and winter respiratory virus season, with health officials urging Americans to get an updated COVID-19 booster and their yearly flu shot.
“Before you visit with your family and friends this holiday season, take a quick test and help keep them safe from COVID-19,” U.S. Health and Human Services Assistant Secretary for Preparedness and Response Dawn O’Connell said in a statement.
U.S. regulators approved an updated COVID-19 vaccine that is designed to combat the recent virus strains and, they hope, forthcoming winter ones, too. Vaccine uptake is waning, however. Most Americans have some immunity from prior infections or vaccinations, but under a quarter of U.S. adults took last fall’s COVID-19 shot.
Using the swab, people can detect current virus strains ahead of the fall and winter respiratory virus season and the holidays. Over-the-counter COVID-19 at-home tests typically cost around $11, as of last year. Insurers are no longer required to cover the cost of the tests.
Before using any existing at-home COVID-19 tests, you should check the expiration date. Many of the tests have been given an extended expiration from the date listed on the box. You can check on the Food and Drug Administration’s website to see if that’s the case for any of your remaining tests at home.
Since COVID-19 first began its spread in 2020, U.S. taxpayers have poured billions of dollars into developing and purchasing COVID-19 tests as well as vaccines. The Biden administration has given out 1.8 billion COVID-19 tests, including half distributed to households by mail. It’s unclear how many tests the government still has on hand.
WASHINGTON (AP) — Americans can once again order free COVID-19 tests sent straight to their homes.
The U.S. government reopened the program on Thursday, allowing any household to order up to four at-home COVID nasal swab kits through the website, covidtests.gov. The tests will begin shipping, via the United States Postal Service, as soon as next week.
The website has been reopened on the heels of a summer COVID-19 virus wave and heading into the fall and winter respiratory virus season, with health officials urging Americans to get an updated COVID-19 booster and their yearly flu shot.
U.S. regulators approved an updated COVID-19 vaccine that is designed to combat the recent virus strains and, they hope, forthcoming winter ones, too. Vaccine uptake is waning, however. Most Americans have some immunity from prior infections or vaccinations, but under a quarter of U.S. adults took last fall’s COVID-19 shot.
Using the swab, people can detect current virus strains ahead of the fall and winter respiratory virus season and the holidays. Over-the-counter COVID-19 at-home tests typically cost around $11, as of last year. Insurers are no longer required to cover the cost of the tests.
Since COVID-19 first began its spread in 2020, U.S. taxpayers have poured billions of dollars into developing and purchasing COVID-19 tests as well as vaccines. The Biden administration has given out 1.8 billion COVID-19 tests, including half distributed to households by mail. It’s unclear how many tests the government still has on hand.
TORONTO – A coalition of disability rights groups says it is launching a Charter challenge against a part of Canada’s law on medical assistance in dying.
The group, which also includes two individual plaintiffs, argues that what’s known as track two of the MAID law has resulted in premature deaths.
Under the law, patients whose natural deaths are not reasonably foreseeable but whose condition leads to intolerable suffering can apply for a track-two assisted death.
The coalition says track two of the MAID law has had a direct effect on the lives of people with disabilities and argues medically assisted death should only be available to those whose natural death is reasonably foreseeable.
The executive vice-president of Inclusion Canada – which is part of the coalition – says there has been an alarming trend where people with disabilities are seeking assisted death due to social deprivation, poverty and a lack of essential supports.
Krista Carr says those individuals should instead be supported in order to live better lives.
This report by The Canadian Press was first published Sept. 26, 2024.
